Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting
Clinical trial NCT04396106 · TERMINATED
Trial details
- NCT number
- NCT04396106
- Sponsor
- Atea Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-26
- Primary completion
- 2022-01-10
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.